Search

Your search keyword '"Chemaitilly, Wassim"' showing total 456 results
Start Over Author "Chemaitilly, Wassim"
456 results on '"Chemaitilly, Wassim"'

3. Prediabetes and Associated Risk of Cardiovascular Events and Chronic Kidney Disease Among Adult Survivors of Childhood Cancer in the St Jude Lifetime Cohort

Author

Dixon, Stephanie B., primary, Wang, Fang, additional, Lu, Lu, additional, Wilson, Carmen L., additional, Green, Daniel M., additional, Merchant, Thomas E., additional, Srivastava, Deo Kumar, additional, Delaney, Angela, additional, Howell, Rebecca M., additional, Jefferies, John L., additional, Robison, Leslie L., additional, Ness, Kirsten K., additional, Hudson, Melissa M., additional, Chemaitilly, Wassim, additional, and Armstrong, Gregory T., additional

Published
2024
Full Text
View/download PDF

4. Hypogonadism and neurocognitive outcomes among childhood cancer survivors

Author

Yoshida, Tomoko, primary, Alexander, Tyler, additional, Xing, Mengqi, additional, Mirzaei, Sedigheh, additional, Williams, AnnaLynn M, additional, Lubas, Margaret, additional, Brinkman, Tara M, additional, Chemaitilly, Wassim, additional, Robison, Leslie L, additional, Hudson, Melissa M, additional, Krull, Kevin R, additional, and Delaney, Angela, additional

Published
2024
Full Text
View/download PDF

8. Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE)

Author

Clark, Rebecca A, Mostoufi-Moab, Sogol, Yasui, Yutaka, Vu, Ngoc Khanh, Sklar, Charles A, Motan, Tarek, Brooke, Russell J, Gibson, Todd M, Oeffinger, Kevin C, Howell, Rebecca M, Smith, Susan A, Lu, Zhe, Robison, Leslie L, Chemaitilly, Wassim, Hudson, Melissa M, Armstrong, Gregory T, Nathan, Paul C, and Yuan, Yan

Published
2020
Full Text
View/download PDF

9. Feasibility of Pegylated Interferon in Children and Young Adults With Resected High‐Risk Melanoma

Author

Navid, Fariba, Herzog, Cynthia E, Sandoval, John, Daryani, Vinay M, Stewart, Clinton F, Gattuso, Jami, Mandrell, Belinda, Phipps, Sean, Chemaitilly, Wassim, Sykes, April, Davidoff, Andrew M, Shulkin, Barry L, Bahrami, Armita, Furman, Wayne L, Mao, Shenghua, Wu, Jianrong, Schiff, Deborah, Rao, Bhaskar, and Pappo, Alberto

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Cancer, Patient Safety, Pediatric, Vaccine Related, Adolescent, Adult, Child, Child, Preschool, Disease-Free Survival, Female, Humans, Interferon alpha-2, Interferon-alpha, Male, Melanoma, Polyethylene Glycols, Recombinant Proteins, Risk Factors, Survival Rate, Young Adult, adjuvant therapy, childhood, high risk, melanoma, pegylated interferon, pharmacokinetics, Clinical Sciences, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis, Oncology and carcinogenesis, Paediatrics
Abstract

BackgroundPegylated interferon α-2b (IFN α-2b) improves disease-free survival in adults with resected stage III melanoma. We conducted a study to determine the feasibility and safety of incorporating pegylated IFN α-2b as adjuvant therapy in the treatment of children and adolescents with high-risk melanoma. Pharmacokinetic studies of IFN α-2b and neuropsychological and quality of life (OL) assessments were performed.Patient and methodsEligible patients with resected American Joint Committee on Cancer Stage IIC, IIIA, and IIIB cutaneous melanoma received nonpegylated IFN α-2b 20 million units/m(2) /day intravenously 5 days per week for 4 weeks (induction) followed by pegylated IFN α-2b 1 μg/kg/dose weekly subcutaneously (SQ) for 48 weeks (maintenance).ResultsTwenty-three patients (15 females, median age 10 years) were enrolled. All patients completed induction therapy; five patients did not complete maintenance therapy either because of recurrent disease (n = 2) or toxicity (n = 3). The most common grade 3 and 4 toxicities of pegylated IFN α-2b were neutropenia (35%) and elevated liver transaminases (17%). The median nonpegylated IFN α-2b AUC0-∞ (5,026 pcg⋅hr/ml) was similar to adults. The median pegylated IFN α-2b exposure (48,480 pcg⋅hr/ml) was greater than the cumulative weekly exposure for nonpegylated IFN α-2b administered SQ three times per week (TIW). Validated measures demonstrated an improvement in QOL scores and no decline in psychological functioning over the course of therapy.ConclusionsPegylated IFN α-2b 1 μg/kg/dose SQ weekly as maintenance therapy in children and adolescents with high-risk melanoma is feasible with tolerable toxicity and appears to yield higher exposures than nonpegylated IFN α-2b administered SQ TIW.

Published
2016

10. Apoptosome activation, an important molecular instigator in 6-mercaptopurine induced Leydig cell death.

Author

Morgan, Jessica A, Lynch, John, Panetta, John C, Wang, Yao, Frase, Sharon, Bao, Ju, Zheng, Jie, Opferman, Joseph T, Janke, Laura, Green, Daniel M, Chemaitilly, Wassim, and Schuetz, John D

Subjects
Leydig Cells, Cell Line, Tumor, Animals, Mice, Transgenic, Humans, Disease Models, Animal, Reactive Oxygen Species, 6-Mercaptopurine, Methotrexate, Caspases, Multidrug Resistance-Associated Proteins, Antimetabolites, Antineoplastic, Apoptosis, Male, Apoptosomes, Mercaptopurine, Cell Line, Tumor, Mice, Transgenic, Disease Models, Animal, Antimetabolites, Antineoplastic
Abstract

Leydig cells are crucial to the production of testosterone in males. It is unknown if the cancer chemotherapeutic drug, 6-mercaptopurine (6 MP), produces Leydig cell failure among adult survivors of childhood acute lymphoblastic leukemia. Moreover, it is not known whether Leydig cell failure is due to either a loss of cells or an impairment in their function. Herein, we show, in a subset of childhood cancer survivors, that Leydig cell failure is related to the dose of 6 MP. This was extended, in a murine model, to demonstrate that 6 MP exposure induced caspase 3 activation, and the loss of Leydig cells was independent of Bak and Bax activation. The death of these non-proliferating cells was triggered by 6 MP metabolism, requiring formation of both cytosolic reactive oxygen species and thiopurine nucleotide triphosphates. The thiopurine nucleotide triphosphates (with physiological amounts of dATP) uniquely activated the apoptosome. An ABC transporter (Abcc4/Mrp4) reduced the amount of thiopurines, thereby providing protection for Leydig cells. The studies reported here demonstrate that the apoptosome is uniquely activated by thiopurine nucleotides and suggest that 6 MP induced Leydig cell death is likely a cause of Leydig cell failure in some survivors of childhood cancer.

Published
2015

16. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study

Author

Mulrooney, Daniel A, Hyun, Geehong, Ness, Kirsten K, Bhakta, Nickhill, Pui, Ching-Hon, Ehrhardt, Matthew J, Krull, Kevin R, Crom, Deborah B, Chemaitilly, Wassim, Srivastava, Deokumar K, Relling, Mary V, Jeha, Sima, Green, Daniel M, Yasui, Yutaka, Robison, Leslie L, and Hudson, Melissa M

Published
2019
Full Text
View/download PDF

17. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)

Author

Bhakta, Nickhill, Liu, Qi, Ness, Kirsten K, Baassiri, Malek, Eissa, Hesham, Yeo, Frederick, Chemaitilly, Wassim, Ehrhardt, Matthew J, Bass, Johnnie, Bishop, Michael W, Shelton, Kyla, Lu, Lu, Huang, Sujuan, Li, Zhenghong, Caron, Eric, Lanctot, Jennifer, Howell, Carrie, Folse, Timothy, Joshi, Vijaya, Green, Daniel M, Mulrooney, Daniel A, Armstrong, Gregory T, Krull, Kevin R, Brinkman, Tara M, Khan, Raja B, Srivastava, Deo K, Hudson, Melissa M, Yasui, Yutaka, and Robison, Leslie L

Published
2017
Full Text
View/download PDF

24. Endocrine System

Author

Chemaitilly, Wassim, McCaffrey, Robert J., Series editor, Fletcher-Janzen, Elaine, Series editor, Mucci, Grace A., editor, and Torno, Lilibeth R., editor

Published
2015
Full Text
View/download PDF

27. Data from Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort

Author

Hudson, Melissa M., primary, Ehrhardt, Matthew J., primary, Bhakta, Nickhill, primary, Baassiri, Malek, primary, Eissa, Hesham, primary, Chemaitilly, Wassim, primary, Green, Daniel M., primary, Mulrooney, Daniel A., primary, Armstrong, Gregory T., primary, Brinkman, Tara M., primary, Klosky, James L., primary, Krull, Kevin R., primary, Sabin, Noah D., primary, Wilson, Carmen L., primary, Huang, I-Chan, primary, Bass, Johnnie K., primary, Hale, Karen, primary, Kaste, Sue, primary, Khan, Raja B., primary, Srivastava, Deo Kumar, primary, Yasui, Yutaka, primary, Joshi, Vijaya M., primary, Srinivasan, Saumini, primary, Stokes, Dennis, primary, Hoehn, Mary Ellen, primary, Wilson, Matthew, primary, Ness, Kirsten K., primary, and Robison, Leslie L., primary

Published
2023
Full Text
View/download PDF

28. Supplemental Table 2 from Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort

Author

Hudson, Melissa M., primary, Ehrhardt, Matthew J., primary, Bhakta, Nickhill, primary, Baassiri, Malek, primary, Eissa, Hesham, primary, Chemaitilly, Wassim, primary, Green, Daniel M., primary, Mulrooney, Daniel A., primary, Armstrong, Gregory T., primary, Brinkman, Tara M., primary, Klosky, James L., primary, Krull, Kevin R., primary, Sabin, Noah D., primary, Wilson, Carmen L., primary, Huang, I-Chan, primary, Bass, Johnnie K., primary, Hale, Karen, primary, Kaste, Sue, primary, Khan, Raja B., primary, Srivastava, Deo Kumar, primary, Yasui, Yutaka, primary, Joshi, Vijaya M., primary, Srinivasan, Saumini, primary, Stokes, Dennis, primary, Hoehn, Mary Ellen, primary, Wilson, Matthew, primary, Ness, Kirsten K., primary, and Robison, Leslie L., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Data from A Novel Locus Predicts Spermatogenic Recovery among Childhood Cancer Survivors Exposed to Alkylating Agents

Author

Sapkota, Yadav, primary, Wilson, Carmen L., primary, Zaidi, Asifa K., primary, Moon, Wonjong, primary, Fon Tacer, Klementina, primary, Lu, Lu, primary, Liu, Qi, primary, Baedke, Jessica, primary, Dhaduk, Rikeenkumar, primary, Wang, Zhaoming, primary, Chemaitilly, Wassim, primary, Krasin, Matthew J., primary, Berry, Fred B., primary, Zhang, Jinghui, primary, Hudson, Melissa M., primary, Robison, Leslie L., primary, Green, Daniel M., primary, and Yasui, Yutaka, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Methods from A Novel Locus Predicts Spermatogenic Recovery among Childhood Cancer Survivors Exposed to Alkylating Agents

Author

Sapkota, Yadav, primary, Wilson, Carmen L., primary, Zaidi, Asifa K., primary, Moon, Wonjong, primary, Fon Tacer, Klementina, primary, Lu, Lu, primary, Liu, Qi, primary, Baedke, Jessica, primary, Dhaduk, Rikeenkumar, primary, Wang, Zhaoming, primary, Chemaitilly, Wassim, primary, Krasin, Matthew J., primary, Berry, Fred B., primary, Zhang, Jinghui, primary, Hudson, Melissa M., primary, Robison, Leslie L., primary, Green, Daniel M., primary, and Yasui, Yutaka, primary

Published
2023
Full Text
View/download PDF

31. Data from A Novel Locus Predicts Spermatogenic Recovery among Childhood Cancer Survivors Exposed to Alkylating Agents

Author

Sapkota, Yadav, primary, Wilson, Carmen L., primary, Zaidi, Asifa K., primary, Moon, Wonjong, primary, Fon Tacer, Klementina, primary, Lu, Lu, primary, Liu, Qi, primary, Baedke, Jessica, primary, Dhaduk, Rikeenkumar, primary, Wang, Zhaoming, primary, Chemaitilly, Wassim, primary, Krasin, Matthew J., primary, Berry, Fred B., primary, Zhang, Jinghui, primary, Hudson, Melissa M., primary, Robison, Leslie L., primary, Green, Daniel M., primary, and Yasui, Yutaka, primary

Published
2023
Full Text
View/download PDF

32. Supplemental Table 1 from Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort

Author

Hudson, Melissa M., primary, Ehrhardt, Matthew J., primary, Bhakta, Nickhill, primary, Baassiri, Malek, primary, Eissa, Hesham, primary, Chemaitilly, Wassim, primary, Green, Daniel M., primary, Mulrooney, Daniel A., primary, Armstrong, Gregory T., primary, Brinkman, Tara M., primary, Klosky, James L., primary, Krull, Kevin R., primary, Sabin, Noah D., primary, Wilson, Carmen L., primary, Huang, I-Chan, primary, Bass, Johnnie K., primary, Hale, Karen, primary, Kaste, Sue, primary, Khan, Raja B., primary, Srivastava, Deo Kumar, primary, Yasui, Yutaka, primary, Joshi, Vijaya M., primary, Srinivasan, Saumini, primary, Stokes, Dennis, primary, Hoehn, Mary Ellen, primary, Wilson, Matthew, primary, Ness, Kirsten K., primary, and Robison, Leslie L., primary

Published
2023
Full Text
View/download PDF

34. Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer

Author

Ehrhardt, Matthew J., primary, Liu, Qi, additional, Dixon, Stephanie B., additional, Caron, Eric, additional, Redd, Debbie, additional, Shelton, Kyla, additional, Huang, I-Chan, additional, Bhakta, Nickhill, additional, Ness, Kirsten K., additional, Mulrooney, Daniel A., additional, Brinkman, Tara M., additional, Chemaitilly, Wassim, additional, Delaney, Angela, additional, Armstrong, Gregory T., additional, Srivastava, Deo Kumar, additional, Zaidi, Alia, additional, Robison, Leslie L., additional, Yasui, Yutaka, additional, and Hudson, Melissa M., additional

Published
2023
Full Text
View/download PDF

38. Premature aging as an accumulation of deficits in young adult survivors of pediatric cancer

Author

Williams, AnnaLynn M, primary, Mandelblatt, Jeanne, additional, Wang, Mingjuan, additional, Armstrong, Gregory T, additional, Bhakta, Nickhill, additional, Brinkman, Tara M, additional, Chemaitilly, Wassim, additional, Ehrhardt, Matthew J, additional, Mulrooney, Daniel A, additional, Small, Brent J, additional, Wang, Zhaoming, additional, Srivastava, Deokumar, additional, Robison, Leslie L, additional, Hudson, Melissa M, additional, Ness, Kirsten K, additional, and Krull, Kevin R, additional

Published
2022
Full Text
View/download PDF

39. Clinical Assessment of Late Health Outcomes in Survivors of Wilms Tumor

Author

Foster, Kayla L., primary, Salehabadi, Sedigheh Mirzaei, additional, Green, Daniel M., additional, Xing, Mengqi, additional, Ness, Kirsten K., additional, Krull, Kevin R., additional, Brinkman, Tara M., additional, Ehrhardt, Matthew J., additional, Chemaitilly, Wassim, additional, Dixon, Stephanie B., additional, Bhakta, Nickhill, additional, Brennan, Rachel C., additional, Krasin, Matthew J., additional, Davidoff, Andrew M., additional, Robison, Leslie L., additional, Hudson, Melissa M., additional, and Mulrooney, Daniel A., additional

Published
2022
Full Text
View/download PDF

42. Bone mineral density (BMD) deficits in adult survivors of childhood cancer: Attributable risks and long-term consequences.

Author

Goodenough, Chelsea Goodliffe, primary, Baedke, Jessica L, additional, Li, Nan, additional, Brinkman, Tara M., additional, Wilson, Carmen Louise, additional, Delaney, Angela M., additional, Inaba, Hiroto, additional, Clark, Karen L, additional, Armstrong, Gregory T., additional, Talleur, Aimee C., additional, Pui, Ching-Hon, additional, Green, Daniel M., additional, Merchant, Thomas E., additional, Srivastava, Deo Kumar, additional, Yasui, Yutaka, additional, Hudson, Melissa M., additional, Robison, Leslie L., additional, Kaste, Sue C., additional, Ness, Kirsten K., additional, and Chemaitilly, Wassim, additional

Published
2022
Full Text
View/download PDF

43. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Author

Boguszewski, Margaret C S, primary, Boguszewski, Cesar L, additional, Chemaitilly, Wassim, additional, Cohen, Laurie E, additional, Gebauer, Judith, additional, Higham, Claire, additional, Hoffman, Andrew R, additional, Polak, Michel, additional, Yuen, Kevin C J, additional, Alos, Nathalie, additional, Antal, Zoltan, additional, Bidlingmaier, Martin, additional, Biller, Beverley M K, additional, Brabant, George, additional, Choong, Catherine S Y, additional, Cianfarani, Stefano, additional, Clayton, Peter E, additional, Coutant, Regis, additional, Cardoso-Demartini, Adriane A, additional, Fernandez, Alberto, additional, Grimberg, Adda, additional, Guðmundsson, Kolbeinn, additional, Guevara-Aguirre, Jaime, additional, Ho, Ken K Y, additional, Horikawa, Reiko, additional, Isidori, Andrea M, additional, Jørgensen, Jens Otto Lunde, additional, Kamenicky, Peter, additional, Karavitaki, Niki, additional, Kopchick, John J, additional, Lodish, Maya, additional, Luo, Xiaoping, additional, McCormack, Ann I, additional, Meacham, Lillian, additional, Melmed, Shlomo, additional, Mostoufi Moab, Sogol, additional, Müller, Hermann L, additional, Neggers, Sebastian J C M M, additional, Aguiar Oliveira, Manoel H, additional, Ozono, Keiichi, additional, Pennisi, Patricia A, additional, Popovic, Vera, additional, Radovick, Sally, additional, Savendahl, Lars, additional, Touraine, Philippe, additional, van Santen, Hanneke M, additional, and Johannsson, Gudmundur, additional

Published
2022
Full Text
View/download PDF

45. Premature Aging as an Accumulation of Deficits in Young Adult Survivors of Pediatric Cancer.

Author

Williams, AnnaLynn M, Mandelblatt, Jeanne, Wang, Mingjuan, Armstrong, Gregory T, Bhakta, Nickhill, Brinkman, Tara M, Chemaitilly, Wassim, Ehrhardt, Matthew J, Mulrooney, Daniel A, Small, Brent J, Wang, Zhaoming, Srivastava, Deokumar, Robison, Leslie L, Hudson, Melissa M, Ness, Kirsten K, and Krull, Kevin R

Subjects
PREMATURE aging (Medicine), CHILDHOOD cancer, YOUNG adults, CANCER survivors, RACE, CANCER fatigue
Abstract

Background: We aimed to characterize premature aging as an accumulation of deficits in survivors of pediatric cancer compared to community controls and examine associations with host/treatment factors, neurocognition, and mortality.Methods: Pediatric cancer survivors (N = 4,000, median age 28.6 [IQR 23-35], 20 [15-27] years post-diagnosis) and community controls (N = 638, median age 32 [25-40]) completed clinical assessments, questionnaires, and were followed for mortality through April 30th, 2020 (mean [SD] follow-up 7.0 [3.4] years). A deficit accumulation index (DAI) score was calculated from 44 aging-related items including: self-reported daily function, psychosocial symptoms, and health conditions. Items were weighted from 0 (absent) to 1 (present/most severe), summed and divided by the total yielding a ratio (higher=more deficits). Scores <0.20 are robust and 0.06 is a clinically meaningful difference. Linear regression compared the DAI in survivors and controls with an age*survivor/control interaction. Logistic regression and Cox-proportional hazards estimated the risk of neurocognitive impairment and death. Models were minimally adjusted for age, sex, and race andethnicity.Results: The adjusted mean DAI among survivors at age 30 years was 0.16 corresponding to age 63 in controls (33 years premature aging; β = 0.07 95%CI 0.06-0.08; p<.001). Cranial/abdominal radiation, alkylators, platinum, and neurosurgery were associated with worse DAI (p's≤.001). Higher scores were associated with increased risk of neurocognitive impairment in all domains (p's<.001) and increased risk of death (DAI 0.20-0.35 HR = 2.80, 95%CI 1.97-3.98; DAI ≥0.35 HR = 5.08, 95%CI 3.52-7.34).Conclusion:  Pediatric cancer survivors experience significant premature aging. The DAI may be used to identify survivors at greatest risk of poor health outcomes. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

47. Dietary protein intake and lean muscle mass in survivors of childhood acute lymphoblastic leukemia: report from the St. Jude lifetime cohort study

Author

Boland, Alexandra M., Gibson, Todd M., Lu, Lu, Kaste, Sue C., DeLany, James P., Partin, Robyn E., Lanctot, Jennifer Q., Howell, Carrie R., Nelson, Heather H., Chemaitilly, Wassim, Pui, Ching-Hon, Robison, Leslie L., Mulrooney, Daniel A., Hudson, Melissa M., and Ness, Kirsten K.

Subjects
Dietary protein -- Health aspects, Muscle weakness -- Analysis, Acute lymphocytic leukemia -- Care and treatment, Health
Abstract

Background. Survivors of childhood acute lymphoblastic leukemia (ALL) are at risk for low lean muscle mass and muscle weakness, which may contribute to inactivity and early development of chronic diseases typically seen in older adults. Although increasing protein intake, in combination with resistance training, improves lean muscle mass in other populations, it is not known whether muscular tissue among survivors of ALL, whose impairments are treatment-related, will respond similarly. Objective. The aim of this study was to evaluate associations among dietary protein intake, resistance training, and lean muscle mass in survivors of ALL and age-, sex-, and race-matched controls. Design. This was a cross-sectional study. Methods. Lean muscle mass was determined with dual-energy x-ray absorptiometry, dietary information with 24-hour recalls, and participation in resistance training with a questionnaire. Participants were 365 survivors of ALL (52% male; 87% white; median age=28.5 years, range=23.6-31-7) and 365 controls with no previous cancer. Results. Compared with controls, survivors of ALL had lower lean muscle mass (55.0 versus 57.2 kg, respectively) and lower percentage of lean muscle mass (68.6% versus 71.4%, respectively) than controls. Similar proportions of survivors (71.1%) and controls (69.7%) met recommended dietary protein intake (0.8 g/kg/d). Survivors (45.4%) were less likely to report resistance training than controls (53.8%). In adjusted models, 1-g higher protein intake per kilogram of body mass per day was associated with a 7.9% increase and resistance training [greater than or equal to] 1 X wk, with a 2.8% increase in lean muscle mass. Limitations. The cross-sectional study design limits temporal evaluation of the association between protein intake and lean muscle mass. Conclusions. The findings suggest that survivors of childhood ALL with low lean muscle mass may benefit from optimizing dietary protein intake in combination with resistance training. Research is needed to determine whether resistance training with protein supplementation improves lean muscle mass in survivors of childhood ALL., Therapies for acute lymphoblastic leukemia (ALL) have acute and late effects on body composition. Loss of lean muscle mass (1) and gains in relative overall body mass (2) are reported [...]

Published
2016
Full Text
View/download PDF

48. Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors

Author

van Iersel, Laura, primary, Mulder, Renee L, additional, Denzer, Christian, additional, Cohen, Laurie E, additional, Spoudeas, Helen A, additional, Meacham, Lillian R, additional, Sugden, Elaine, additional, Schouten-van Meeteren, Antoinette Y N, additional, Hoving, Eelco W, additional, Packer, Roger J, additional, Armstrong, Gregory T, additional, Mostoufi-Moab, Sogol, additional, Stades, Aline M, additional, van Vuurden, Dannis, additional, Janssens, Geert O, additional, Thomas-Teinturier, Cécile, additional, Murray, Robert D, additional, Di Iorgi, Natascia, additional, Neggers, Sebastian J C M M, additional, Thompson, Joel, additional, Toogood, Andrew A, additional, Gleeson, Helena, additional, Follin, Cecilia, additional, Bardi, Edit, additional, Torno, Lilibeth, additional, Patterson, Briana, additional, Morsellino, Vera, additional, Sommer, Grit, additional, Clement, Sarah C, additional, Srivastava, Deokumar, additional, Kiserud, Cecilie E, additional, Fernandez, Alberto, additional, Scheinemann, Katrin, additional, Raman, Sripriya, additional, Yuen, Kevin C J, additional, Wallace, W Hamish, additional, Constine, Louis S, additional, Skinner, Roderick, additional, Hudson, Melissa M, additional, Kremer, Leontien C M, additional, Chemaitilly, Wassim, additional, and van Santen, Hanneke M, additional

Published
2021
Full Text
View/download PDF

49. Primary hypothyroidism in childhood cancer survivors: Prevalence, risk factors, and long‐term consequences

Author

Chemaitilly, Wassim, primary, Li, Zhenghong, additional, Brinkman, Tara M., additional, Delaney, Angela, additional, Huang, Sujuan, additional, Bjornard, Kari L., additional, Lam, Catherine G., additional, Wilson, Carmen L., additional, Barnes, Nicole, additional, Clark, Karen L., additional, Krasin, Matthew J., additional, Metzger, Monika L., additional, Sheyn, Anthony, additional, Bishop, Michael W., additional, Sabin, Noah D., additional, Howell, Rebecca M., additional, Helmig, Sara, additional, Shulkin, Barry L., additional, Triplett, Brandon M., additional, Pui, Ching‐Hong, additional, Gajjar, Amar, additional, Srivastava, Deo Kumar, additional, Green, Daniel M., additional, Armstrong, Gregory T., additional, Robison, Leslie L., additional, Hudson, Melissa M., additional, Ness, Kristen K., additional, Sklar, Charles A., additional, and Krull, Kevin R., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results